Mind Cure Health Announces $3.0 Million Financing

Mind Cure Health (CSE: MCUR) this morning announced that it is conducting a non-brokered private placement. The financing is looking to raise $3.0 million in gross proceeds at a price of $0.45 per unit.

Each unit sold under the offering is to consist of one common share and one common share purchase warrant. Warrants have an exercise price of $0.60, and an expiry of two years following the close of the transaction. A total of 6,666,666 units are expected to be sold under the offering.

Proceeds from the offering have been earmarked for a number of purposes, with the primary function being that of the evaluation of new product candidates. Also included is that of supporting the existing product line, increasing spending for investor relations, advertising and marketing, and hiring additional persons to push forward the companies business goals. Naturally, the remainder will be spent on general working capital purposes.

The offering is expected to close next week, with the company indicating that it has received subscription commitments for an aggregate amount of $3.0 million. The commitments are said to come from subscribers under a number of prospectus exemptions.

Mind Cure Health last traded at $0.58 on the CSE.


FULL DISCLOSURE: Mind Cure Health is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Mind Cure Health on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Why the Market May Be Misreading Iran | David Woo

Why US Fertilizer Supply Could Matter a Lot More Now | Pat Varas – Sage Potash

Roscan Gold: Mali Discount Hits Kandiole PEA

Recommended

CityNews Reporter Fired As Her Doug Ford Stories Disappear

First Phosphate Gains Danish State Support With LOI For EUR 170 Million Credit Guarantee

Related News

Mind Cure Health Receives Ethics Approval For Psychedelic Integration Protocol Study

Mind Cure Health (CSE: MCUR) has seen its integration protocol research study receive unconditional ethics...

Tuesday, March 9, 2021, 08:43:32 AM

Mind Cure: Mental Health Focused Firm To Commence Trading Monday

Mind Cure Health (CSE: MCUR) is the latest issue to hit the Canadian Securities Exchange...

Sunday, September 20, 2020, 09:00:00 AM

Mind Cure Appoints Kelsey Ramsden As CEO And President

Mind Cure Health (CSE: MCUR) has shaken up its management team slightly, promoting COO Kelsey...

Tuesday, December 1, 2020, 08:51:06 AM

Mind Cure Gives Up On Psychedelics, Fires C-Suite, And Reverts To Shell After Strategic Review

In a sign of what’s to come for most psychedelic-related names, Mind Cure Health (CSE:...

Wednesday, March 16, 2022, 11:58:00 AM

Mind Cure Announces $10.0 Million Bought Deal Financing

Mind Cure Health (CSE: MCUR) this afternoon revealed that it is conducting a bought deal...

Thursday, January 21, 2021, 04:01:29 PM